Sun Pharma Advanced Research Company Ltd. (SPARC) and Sun Pharma today announced a licensing arrangement for SPARC's ELEPSIA XRTM (Levetiracetam Extended Release tablets). After the news came early in the morning, Sun Pharma share price opened with a rise, meager, but a rise. As per the agreement, SPARC will license ELEP